An antibody discovery platform revealed more than 60 monoclonal antibodies specific to patients with alpha-gal syndrome, ...
Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals ...
4d
News Medical on MSN‘Flesh-eating’ fungus: Fatal infection on the rise but this new antibody treatment could change everything, says studyAs a result, Ibrahim and Gu developed an antibody called VX-01, a humanized antibody that has proven more effective at ...
Research from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago strongly ...
An experimental drug reduced the risk of developing symptoms of Alzheimer's disease by half in people with a rare genetic ...
Eli Lilly is expanding care offerings on its direct-to-consumer (DTC) platform LillyDirect, now offering connections to ...
EMA accepts for review GSK’s application to expand use of Nucala for COPD treatment: London, UK Wednesday, March 26, 2025, 11:00 Hrs [IST] GSK plc announced that the European Me ...
The average treatment effect in the treated hazard ratio among those who received sotrovimab was 0.92 (95% confidence ...
A new study published in The Journal of Dermatology revealed that patients with palmoplantar pustulosis (PPP) who were 18 ...
Stomach cancer rates in the United States have been steadily decreasing for decades, but recent trends reveal an increase in early-onset stomach cancer in people younger than 50, particularly women.
Avidity Biosciences, Inc.'s innovative AOC platform and promising clinical programs make it a high-risk, high-reward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results